nach oben

Erschienen in:

31.01.2023 | COVID-19

Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil

verfasst von: Ryan C. Silva, Michelle M. da Rosa, Heloísa I. Leão, Eduardo D. L. Silva, Nathália T. Ferreira, Amanda P. B. Albuquerque, Gisele S. Duarte, André M. Siqueira, Michelly C. Pereira, Moacyr J. B. M. Rêgo, Maira G. R. Pitta

Erschienen in: Journal of NeuroVirology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Neurological symptoms have been often reported in COVID-19 disease. In the present study, we evaluated brain damage associated with the increase of serum levels of neurological biomarkers S100B and neuron-specific enolase (NSE) induced by SARS-CoV-2 infection, in a population from Northeastern Brazil. Thirty-six healthy control (G1) individuals and 141 patients with confirmed COVID-19 were enrolled in this study. Positive-COVID-19 patients were divided into two groups according to the severity of illness by the National Institute of Health (NIH) criteria, 76 patients with mild symptoms for COVID-19 and (G2) and 65 with acute respiratory conditions requiring supplemental oxygenation via intensive care unit (ICU) admission (G3). A follow-up study was conducted with 23 patients from G2 14 (D14) and 21 (D21) days after the onset of symptoms. Serum levels of NSE and S100B were measured using the enzyme-linked immunoassay method (ELISA). Results revealed a significant positive association between G3 patients and S100B serum expression (p = 0.0403). The serum levels of NSE were also significantly enhanced in the G3 group compared to the control (p < 0.0001) and G2 group (p < 0.0001). In addition, clinical features such as symptoms and oxygenation status were not correlated with NSE or S100B serum expression. The follow-up study demonstrated a decrease over time (21 days) in NSE serum expression (p < 0.0001). These results suggest that brain damage is followed by acute virus exposure, with no long-term effects. Future work examining COVID-19 recovery will shed light on chronic neurological damage of SARS-CoV-2 infection.

Aceti A, Margarucci LM, Scaramucci E, Orsini M, Salerno G, Di Sante G, Gianfranceschi G et al (2020) Serum S100B protein as a marker of severity in Covid-19 patients. Sci Rep. https://doi.org/10.1038/s41598-020-75618-0CrossRefPubMedPubMedCentral

Ananthaharan A, Kravdal G, Straume-Naesheim TM (2018) Utility and effectiveness of the Scandinavian guidelines to exclude computerized tomography scanning in mild traumatic brain injury - a prospective cohort study. BMC Emerg Med 18(1):1–8. https://doi.org/10.1186/s12873-018-0193-2CrossRef

Arrais AC, Melo LHMF, Norrara B, Almeida MAB, Freire KF, Melo AMMF, de Oliveira LC et al (2020) S100B protein: general characteristics and pathophysiological implications in the central nervous system. Int J Neurosci. https://doi.org/10.1080/00207454.2020.1807979CrossRefPubMed

Ben Abdesselam O, Vally J, Adem C, Foglietti M-J, Beaudeux J-L (2003) Reference values for serum S-100B protein depend on the race of individuals. Clin Chem 49(5):836–837. https://doi.org/10.1373/49.5.836CrossRefPubMed

Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R et al (2020) The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier. Neurobiol Dis 146:105131. https://doi.org/10.1016/j.nbd.2020.105131CrossRefPubMedPubMedCentral

Chen N, Zhou M, Dong X, Jieming Qu, Gong F, Han Y, Qiu Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7CrossRefPubMedPubMedCentral

Cione E, Siniscalchi A, Gangemi P, Cosco L, Colosimo M, Longhini F, Luciani F et al (2021) Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury. PLoS ONE. https://doi.org/10.1371/journal.pone.0251819CrossRefPubMedPubMedCentral

Erickson MA, Rhea EM, Knopp RC, Banks WA (2021) Interactions of Sars-Cov-2 with the blood–brain barrier. Int J Mol Sci 22(5):1–28. https://doi.org/10.3390/IJMS22052681CrossRef

Fiori P, Allegorico L, Capaldo G, Corbo A, Massarelli M, Gizzi R, Pelosi C et al (2021) Neuron specific enolase in a SARS CoV2 Patient. J Neurol Sci 429(2021):119815. https://doi.org/10.1016/j.jns.2021.119815CrossRefPubMedCentral

Flumignan VZ (2020) Timeline and outcome of anosmia and ageusia associated with Covid-19 infection: a case report. Adv Case Stud 2(4):2–5. https://doi.org/10.31031/AICS.2020.02.000544

Ganti L, Serrano E, Toklu HZ (2020) Can neuron specific enolase be a diagnostic biomarker for neuronal injury in COVID-19? Cureus 12(10):10–13. https://doi.org/10.7759/cureus.11033CrossRef

Garg RK, Paliwal VK, Gupta A (2021) Encephalopathy in patients with COVID-19: a review. J Med Virol 93(1):206–222. https://doi.org/10.1002/jmv.26207CrossRefPubMed

Isgrò MA, Bottoni P, Scatena R (2015) Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol 867:125–143. https://doi.org/10.1007/978-94-017-7215-0_9CrossRefPubMed

Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, An J et al (2021) Flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 Infection. Stroke. https://doi.org/10.1161/STROKEAHA.120.032764CrossRefPubMed

Kaye R, David Chang CW, Kazahaya K, Brereton J, Denneny JC (2020) COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg (United States). https://doi.org/10.1177/0194599820922992CrossRef

Kokkoris S, Stamataki E, Emmanouil G, Psachoulia C, Ntaidou T, Maragouti A, Kanavou A et al (2022) Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit : a pilot study. ENeurologicalSci 29:100434. https://doi.org/10.1016/j.ensci.2022.100434CrossRefPubMedPubMedCentral

Liu J, Shi Y, Tang J, Guo T, Li X, Yang Y, Chen Q et al (2005) SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem Biophys Res Commun 328(1):335–341. https://doi.org/10.1016/j.bbrc.2004.12.175CrossRefPubMed

Lu K, Xiaofeng Xu, Cui S, Wang F, Zhang B, Zhao Y (2015) Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. J Neurol Sci 359(1–2):202–206. https://doi.org/10.1016/j.jns.2015.10.034CrossRefPubMed

Mao L, Wang M, Chen S, He Q, Chang J, Hong C, Zhou Y et al (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Electron J. https://doi.org/10.2139/ssrn.3544840CrossRef

Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24(2):168–175. https://doi.org/10.1038/s41593-020-00758-5CrossRefPubMed

Mete E, Sabirli R, Goren T, Turkcuer I, Kurt Ö, Koseler A (2021). Association between S100b levels and Covid-19 pneumonia: a case control study. In Vivo 35(5):2923–2928. https://doi.org/10.21873/INVIVO.12583

Miao Q, Cai B, Gao X, Zhenzhen Su, Zhang J (2020) The establishment of neuron-specific enolase reference interval for the healthy population in Southwest China. Sci Rep. https://doi.org/10.1038/s41598-020-63331-xCrossRefPubMedPubMedCentral

Michetti F, Di Sante G, Clementi ME, Sampaolese B, Casalbore P, Volonté C, Parnigotto PP, Di Liddo R, Amadio S, Ria F (2021) Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders. Neurosci Biobehav Rev 127:446–458. https://doi.org/10.1016/j.neubiorev.2021.04.035CrossRefPubMed

Sahin BE, Celikbilek A, Kocak Y, Saltoglu GT, Konar NM, Hizmali L (2022) Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci 439:120324. https://doi.org/10.1016/j.jns.2022.120324CrossRefPubMedPubMedCentral

Savarraj J, Park ES, Colpo GD, Hinds SN, Morales D, Ahnstedt H, Paz AS et al (2021) Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J Neuroinflammation 18(1):1–12. https://doi.org/10.1186/s12974-021-02323-8CrossRef

Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander BM, Nelson DW (2016) Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit Care 20(1):1–15. https://doi.org/10.1186/s13054-016-1450-yCrossRef

Thelin EP, Nelson DW, Bellander BM (2017) A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir. https://doi.org/10.1007/s00701-016-3046-3CrossRefPubMed

Wei X, Jingyu Su, Yang K, Wei J, Wan H, Cao X, Tan W, Wang H (2020) Elevations of serum cancer biomarkers correlate with severity of COVID-19. J Med Virol 92(10):2036–2041. https://doi.org/10.1002/jmv.25957CrossRefPubMedPubMedCentral

Titel: Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil
verfasst von: Ryan C. Silva
Michelle M. da Rosa
Heloísa I. Leão
Eduardo D. L. Silva
Nathália T. Ferreira
Amanda P. B. Albuquerque
Gisele S. Duarte
André M. Siqueira
Michelly C. Pereira
Moacyr J. B. M. Rêgo
Maira G. R. Pitta
Publikationsdatum: 31.01.2023
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Journal of NeuroVirology / Ausgabe 2/2023
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-023-01119-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV

Central nervous system reactivation of herpesviridae family in patients with COVID-19

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial

Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma

Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study

Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie